|
|
Office Locations:
|
525 University Ave., Suite 1350
Palo Alto, CA 94301
Phone: 650-327-8800
Fax: 650-324-8838
| | |
|
|
|
- Early
- Expansion
- Growth
- Seed
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
With $1 billion of capital under management, Prospect Venture Partners invests in biomedical technology and life science companies. Prospect seeks to ultimately invest $10-20 million in each company in its portfolio, typically as a lead investor or as a co-lead in an investor syndicate. The firm invests in companies with a broad range of development and financing requirements including: incubating new companies, investing in first and second venture financing rounds, and participating in later stage private and public companies (with proven business models requiring expansion capital). First round investments most often range from $500,000 to $10 million. The partners at Prospect Ventures have led investments in more than 50 companies and have an established track record of working closely with management teams in early and growth stage enterprises.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
